Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

February 10, 2026 09:00 ET | Source: Truveta

FDA cardiovascular indication for semaglutide led to short-term uptake but persistent treatment gaps among high-risk patients, new Truveta study finds

BELLEVUE, Wash., Feb. 10, 2026 (GLOBE NEWSWIRE) -- A new peer-reviewed study led by Truveta Research and collaborators finds that the US Food and Drug Administration’s (FDA) March 2024 expansion of...
January 31, 2025 11:18 ET | Source: Truveta

New Truveta study highlights patterns of discontinuation and reinitiation of GLP-1 RA medications

BELLEVUE, Wash., Jan. 31, 2025 (GLOBE NEWSWIRE) -- Truveta’s groundbreaking study analyzing real-world use of GLP-1 receptor agonist (GLP-1 RA) therapies in adults with overweight or obesity has...